These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7278494)

  • 21. Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus, not the cerebral cortex.
    Reynolds GP; Pearson SJ; Heathfield KW
    Neurosci Lett; 1990 May; 113(1):95-100. PubMed ID: 1973277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscarinic receptor compensation in hippocampus of Alzheimer patients.
    Nordberg A; Larsson C; Adolfsson R; Alafuzoff I; Winblad B
    J Neural Transm; 1983; 56(1):13-9. PubMed ID: 6133910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
    Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
    Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.
    Yates CM; Simpson J; Gordon A
    Neurosci Lett; 1986 Apr; 65(2):189-92. PubMed ID: 2940479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.
    Arai H; Moroji T; Kosaka K
    Neurosci Lett; 1984 Nov; 52(1-2):73-8. PubMed ID: 6152043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholinergic and dopaminergic activities in senile dementia of Lewy body type.
    Perry EK; Marshall E; Perry RH; Irving D; Smith CJ; Blessed G; Fairbairn AF
    Alzheimer Dis Assoc Disord; 1990; 4(2):87-95. PubMed ID: 2357341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.
    Henke H; Lang W
    Brain Res; 1983 May; 267(2):281-91. PubMed ID: 6871677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain muscarinic receptors in senile dementia.
    Rinne JO; Laakso K; Lönnberg P; Mölsä P; Paljärvi L; Rinne JK; Säkö E; Rinne UK
    Brain Res; 1985 Jun; 336(1):19-25. PubMed ID: 4005573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Qualitative abnormalities of choline acetyltransferase in Alzheimer type dementia.
    Koshimura K; Kato T; Tohyama I; Nakamura S; Kameyama M
    J Neurol Sci; 1986 Dec; 76(2-3):143-50. PubMed ID: 3794747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ageing brain and dementia--a review.
    Davison AN
    Br J Clin Pract Suppl; 1985 Jun; 39():3-6. PubMed ID: 2864054
    [No Abstract]   [Full Text] [Related]  

  • 33. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
    Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M
    Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemistry of Dementias.
    Bowen DM
    Proc R Soc Med; 1977 May; 70(5):351-3. PubMed ID: 141671
    [No Abstract]   [Full Text] [Related]  

  • 35. An update on the neurochemistry of Alzheimer disease.
    Davies P
    Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134
    [No Abstract]   [Full Text] [Related]  

  • 36. CCK receptors and human neurological disease.
    Hays SE; Paul SM
    Life Sci; 1982 Jul; 31(4):319-22. PubMed ID: 6292647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotransmitters in dementia.
    Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
    Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients.
    Farmery SM; Owen F; Poulter M; Crow TJ
    Life Sci; 1985 Feb; 36(5):473-7. PubMed ID: 3968973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism.
    Tamminga CA; Foster NL; Fedio P; Bird ED; Chase TN
    Neurology; 1987 Jan; 37(1):161-5. PubMed ID: 2879258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nucleus basalis in Huntington's disease.
    Clark AW; Parhad IM; Folstein SE; Whitehouse PJ; Hedreen JC; Price DL; Chase GA
    Neurology; 1983 Oct; 33(10):1262-7. PubMed ID: 6225032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.